Cc1c2c(c(O)c3c(O)cccc13)C(=O)C1(O)C(=O)C(C(=O)NCNc3ccc(C(N)=O)cn3)=C(O)C(N(C)C)C1C2.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?